(Q46040000)

18 December 2017

title

HTR2A A-1438G/T102C polymorphisms predict negative symptoms performance upon aripiprazole treatment in schizophrenic patients. (English)

1 reference

18 December 2017

0 references

Shih-Fen Chen

1

1 reference

18 December 2017

Yu-Chih Shen

series ordinal

2

1 reference

18 December 2017

Chia-Hsiang Chen

series ordinal

3

1 reference

18 December 2017

publication date

23 April 2009

1 reference

18 December 2017

published in

Psychopharmacology

1 reference

18 December 2017

volume

205

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

285-292

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-009-1538-z

exact match

0 references

cites work

Other method for adjustment of multiple testing exists

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1538-Z

Negative symptoms of schizophrenia could explain discrepant data on the association between the 5-HT2A receptor gene and response to antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1538-Z

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1538-Z

Adjusting for multiple testing in studies is less important than other concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1538-Z

Treatment of schizophrenia negative symptoms: future prospects

21 January 2018

1 reference

12 December 2020

5-HT2A receptor promoter polymorphism, -1438G/A and negative symptom response to olanzapine in schizophrenia

1 reference

12 December 2020

Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine

1 reference

12 December 2020

The serotonin receptor subtype 2 locus HTR2 is on human chromosome 13 near genes for esterase D and retinoblastoma-1 and on mouse chromosome 14.

1 reference

12 December 2020

An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis

1 reference

12 December 2020

Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole

1 reference

12 December 2020

Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors

1 reference

12 December 2020

The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity

1 reference

12 December 2020

Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole

1 reference

12 December 2020

Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist

1 reference

12 December 2020

Genetic variation of the 5-HT2A receptor and response to clozapine

1 reference

12 December 2020

Genetic variation of the 5-HT2A receptor and response to clozapine

1 reference

12 December 2020

Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?

1 reference

12 December 2020

DNA methylation and the regulation of gene transcription

1 reference

12 December 2020

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

1 reference

12 December 2020

Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.

1 reference

12 December 2020

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene

1 reference

12 December 2020

Association between clozapine response and allelic variation in 5-HT2A receptor gene

1 reference

12 December 2020

Association between 5-HT2A gene promoter polymorphism and anorexia nervosa

1 reference

12 December 2020

Genetic variation of 5-HT2A receptor and response to clozapine

1 reference

12 December 2020

Allele C-specific methylation of the 5-HT2A receptor gene: evidence for correlation with its expression and expression of DNA methylase DNMT1.

1 reference

12 December 2020

Worsening schizoaffective disorder with aripiprazole

1 reference

12 December 2020

Duration of illness and structure of symptoms in schizophrenia

1 reference

12 December 2020

Methylation-induced repression--belts, braces, and chromatin

1 reference

12 December 2020

Aripiprazole: an overview of a novel antipsychotic.

1 reference

12 December 2020

Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting

1 reference

12 December 2020

Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine.

1 reference

12 December 2020

Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.

1 reference

12 December 2020

Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients

1 reference

12 December 2020

Pharmacogenetics of psychotropic drug response

1 reference

12 December 2020

10.1007/S00213-009-1538-Z

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

19387614

1 reference

18 December 2017